2 results match your criteria: "USA. ltobler@bloodcenters.org[Affiliation]"
Impact of HCV 3.0 EIA relative to HCV 2.0 EIA on blood-donor screening.
Transfusion
October 2003
Blood Centers of the Pacific, Irwin Center, San Francisco, California 94118, USA.
Background: In 1996, the Ortho HCV Version 3.0 ELISA Test System (HCV 3.0 EIA) was licensed in the United States for donor screening but was neither mandated nor universally implemented.
View Article and Find Full Text PDFPerformance of second- and third-generation RIBAs for confirmation of third-generation HCV EIA-reactive blood donations. Retrovirus Epidemiology Donor Study.
Transfusion
August 2000
Blood Centers of the Pacific-Irwin Center, San Francisco, CA 94118, USA.
Background: Licensure of an enhanced HCV screening assay (HCV 3.0 EIA) without concurrent licensure of a complementary supplemental assay (i.e.
View Article and Find Full Text PDF